RT Journal Article
SR Electronic
A1 Kuznar, Wayne
T1 SC Tocilizumab Reduces RA Disease Activity When Used with DMARDs
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 19
SP 18
OP 19
DO 10.1177/155989771219015
UL http://mdc.sagepub.com/content/12/19/18.2.abstract
AB When used in combination with traditional disease-modifying antirheumatic drugs, response rates were significantly superior with a subcutaneous form of tocilizumab compared with placebo in a 24-week Phase 3 study of patients with moderate to severe rheumatoid arthritis.